{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:32:32Z","timestamp":1792272752470,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.antiviral.2020.104873","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T23:19:56Z","timestamp":1594336796000},"page":"104873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":290,"special_numbering":"C","title":["Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0228-2393","authenticated-orcid":false,"given":"So Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0551-0291","authenticated-orcid":false,"given":"Weihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-7917","authenticated-orcid":false,"given":"Amika","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8112-8695","authenticated-orcid":false,"given":"David W.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver C.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-3874","authenticated-orcid":false,"given":"Li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-3702","authenticated-orcid":false,"given":"Jonathan S.","family":"Dordick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2400-6293","authenticated-orcid":false,"given":"Robert J.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Linhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104873_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-34521-1_32","article-title":"Heparanase, heparan sulfate and viral infection","author":"Agelidis","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.antiviral.2020.104873_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-020-02162-z","article-title":"The association between treatment with heparin and survival in patients with Covid-19","author":"Ayerbe","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.antiviral.2020.104873_bib3","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2020.104873_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104873_bib5","first-page":"21","article-title":"Molecular modeling of protein-glycosaminoglycan interactions","volume":"9","author":"Cardin","year":"1989","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.antiviral.2020.104873_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2020.104873_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2020.104873_bib8","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104873_bib9","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1128\/JVI.00074-08","article-title":"Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation","volume":"82","author":"de Haan","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104873_bib10","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.1128\/JVI.79.22.14451-14456.2005","article-title":"Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor","volume":"79","author":"de Haan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104873_bib11","series-title":"Can Nebuilsed Heparin Reduce Time to Extubation in SARS-CoV-2 (CHARTER Study) - Protocol","author":"Dixon","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104873_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.virol.2006.02.003","article-title":"Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry","volume":"350","author":"Follis","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104873_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1183\/09059180.05.00009703","article-title":"Matrix proteoglycans as effector molecules for epithelial cell function","volume":"14","author":"Frevert","year":"2005","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.antiviral.2020.104873_bib14","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jps.23501","article-title":"Structural characterization of pharmaceutical heparins prepared from different animal tissues","volume":"102","author":"Fu","year":"2013","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.antiviral.2020.104873_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104873_bib16","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.xphs.2016.03.037","article-title":"Comparison of low-molecular-weight heparins prepared from bovine lung heparin and porcine intestine heparin","volume":"105","author":"Guan","year":"2016","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.antiviral.2020.104873_bib17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R","article-title":"Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins","volume":"20","author":"Hileman","year":"1998","journal-title":"Bioessays"},{"key":"10.1016\/j.antiviral.2020.104873_bib18","doi-asserted-by":"crossref","first-page":"15231","DOI":"10.1021\/bi980212x","article-title":"Thermodynamic analysis of the heparin interaction with a basic cyclic peptide using isothermal titration calorimetry","volume":"37","author":"Hileman","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104873_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104873_bib20","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1074\/jbc.M508381200","article-title":"SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells","volume":"281","author":"Huang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104873_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.antiviral.2020.104873_bib22","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1021\/bi0352320","article-title":"Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly","volume":"43","author":"Ibrahimi","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104873_bib23","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0008-6215(02)00229-X","article-title":"Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site","volume":"337","author":"Islam","year":"2002","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.antiviral.2020.104873_bib24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/brv.12034","article-title":"Glycosaminoglycans in infectious disease","volume":"88","author":"Kamhi","year":"2013","journal-title":"Biol. Rev."},{"key":"10.1016\/j.antiviral.2020.104873_bib25","doi-asserted-by":"crossref","first-page":"15381","DOI":"10.1074\/jbc.RA118.001904","article-title":"Copper regulates the interactions of antimicrobial piscidin peptides from fish mast cells with formyl peptide receptors and heparin","volume":"293","author":"Kim","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104873_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1021\/acs.biochem.6b01056","article-title":"Interaction of zika virus envelope protein with glycosaminoglycans","volume":"56","author":"Kim","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104873_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104873_bib28","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104873_bib29","series-title":"Essentials of Glycobiology","article-title":"Proteoglycans and sulfated glycosaminoglycans","author":"Lindahl","year":"2015"},{"key":"10.1016\/j.antiviral.2020.104873_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-2007-982076","article-title":"Enzymatic synthesis of glycosaminoglycan heparin","volume":"33","author":"Linhardt","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.antiviral.2020.104873_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.00683-18","article-title":"Middle East respiratory syndrome coronavirus spike protein is not activated directly by cellular furin during viral entry into target cells","volume":"92","author":"Matsuyama","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104873_bib32","author":"Mycroft-west"},{"key":"10.1016\/j.antiviral.2020.104873_bib33","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acs.jctc.5b00834","article-title":"Vina-carb: improving glycosidic angles during carbohydrate docking","volume":"12","author":"Nivedha","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.antiviral.2020.104873_bib34","series-title":"Unfractionated Heparin Potently Inhibits the Binding of SARS-CoV-2 Spike Protein to a Human Cell Line","author":"Partridge","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104873_bib35","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1016\/j.febslet.2007.11.050","article-title":"Heparin enhances the furin cleavage of HIV-1 gp160 peptides","volume":"581","author":"Pasquato","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2020.104873_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104873_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/glycob\/cwz027","article-title":"GAG Builder: a web-tool for modeling 3D structures of glycosaminoglycans","volume":"29","author":"Singh","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.antiviral.2020.104873_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/BJ20040984","article-title":"The SARS coronavirus nucleocapsid protein induces actin reorganization and apoptosis in COS-1 cells in the absence of growth factors","volume":"383","author":"Surjit","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2020.104873_bib39","series-title":"Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives","author":"Tandon","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104873_bib40","article-title":"SARS-COV-2 and infectivity: possible increase in infectivity associated to integrin motif expression","volume":"1\u20132","author":"Tresoldi","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104873_bib41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and updates AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2020.104873_bib42","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"1\u20133","author":"van Doremalen","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104873_bib43","first-page":"1","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"180","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104873_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2020.104873_bib45","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2020.104873_bib46","series-title":"WHO Director-General\u2019s Opening Remarks at the Mission Briefing on COVID-19 -11 March 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104873_bib47","series-title":"Coronavirus Disease 2019 (COVID-19)","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104873_bib48","series-title":"Clinical Management of Severe Acute Respiratory Infection when Novel Coronavirus (2019-nCoV) Infection Is Suspected","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104873_bib49","first-page":"1260","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science 80"},{"key":"10.1016\/j.antiviral.2020.104873_bib50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-6215(96)90611-4","article-title":"1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives","volume":"294","author":"Yates","year":"1996","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.antiviral.2020.104873_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S2468-1253(20)30048-0","article-title":"Enteric involvement of coronaviruses: is faecal\u2013oral transmission of SARS-CoV-2 possible?","volume":"5","author":"Yeo","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220302874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:24Z","timestamp":1759062684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220302874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"alternative-id":["S0166354220302874"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104873","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104873"}}